4.7 Article

SARS-CoV-2 Prevalence in Malawi Based on Data from Survey of Communities and Health Workers in 5 High-Burden Districts, October 2020

Journal

EMERGING INFECTIOUS DISEASES
Volume 28, Issue -, Pages S76-S84

Publisher

CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2813.212348

Keywords

-

Funding

  1. President's Emergency Plan for AIDS Relief through the Centers for Disease Control and Prevention [GH002038]
  2. Norwegian Agency for Development Cooperation [QZA-15/0505]

Ask authors/readers for more resources

This study conducted a multistage cluster survey in 5 districts of Malawi to determine the early burden of COVID-19, finding infection prevalence and seroprevalence among both community members and health facility staff. Most of the infected participants were asymptomatic, with higher seroprevalence in urban areas. The cumulative infection findings were significantly higher compared to national statistics, highlighting the importance of identifying alternative surveillance approaches and predictors of severe disease.
To determine early COVID-19 burden in Malawi, we conducted a multistage cluster survey in 5 districts. During October-December 2020, we recruited 5,010 community members (median age 32 years, interquartile range 21-43 years) and 1,021 health facility staff (HFS) (median age 35 years, interquartile range 28-43 years). Real-time PCR-confirmed SARS-CoV-2 infection prevalence was 0.3% (95% CI 0.2%-0.5%) among community and 0.5% (95% CI 0.1%-1.2%) among HFS participants; seroprevalence was 7.8% (95% CI 6.3%-9.6%) among community and 9.7% (95% CI 6.4%-14.5%) among HFS participants. Most seropositive community (84.7%) and HFS (76.0%) participants were asymptomatic. Seroprevalence was higher among urban community (12.6% versus 3.1%) and HFS (14.5% versus 7.4%) than among rural community participants. Cumulative infection findings 113-fold higher from this survey than national statistics (486,771 versus 4,319) and predominantly asymptomatic infections highlight a need to identify alternative surveillance approaches and predictors of severe disease to inform national response.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available